Alembic Pharmaceuticals informs about press release

02 Aug 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Nelarabine Injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial). It has enclosed press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

895.15 15.90 (1.81%)
30-Apr-2025 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.45
Dr. Reddys Lab 1186.40
Cipla 1562.00
Lupin 2103.70
Zydus Lifesciences 896.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...